Unicycive Therapeutics (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced the enrollment of the first patient in its open-label, single-arm, multicenter, multidose pivotal clinical trial with Oxylanthanum Carbonate (OLC). OLC is a next-generation lanthanum-based phosphate binding agent utilizing proprietary nanoparticle technology being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.

American Resources Corp. (Nasdaq: AREC), a next generation and socially responsible supplier of rare earth and critical elements, and Royalty Management Holding Corp. (Nasdaq: RMCO), a royalty company building shareholder value to benefit both its shareholders and communities by acquiring and developing high-value assets in a sustainable market environment, have announced that their partner and investments in Advanced Magnetic Labs, Inc. has announced a successful year of advancing its technology, capabilities, and strategic relationships for positioning into commercial manufacturing of permanent magnet products.

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced that it has extinguished $18.13 million in convertible notes, 15 months ahead of schedule.

Royalty Management Holding Corp. (Nasdaq: RMCO), an innovative royalty company building shareholder value by acquiring and developing high value assets in a sustainable market environment, iannounced that Ferrox Holdings Ltd., an investment holding of the Company, has confirmed the commencement of production of titanium ferrite from its Tivani operating site.